Aspire Bariatrics Announces AspireAssist® Receives Australian TGA Approval and First Commercial Cases Performed in Australia
KING OF PRUSSIA, Pa., June 21, 2017 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical device company announced today that it received approval to market the AspireAssist®, a novel device for the treatment of obesity, in Australia by …